US short seller Andrew Left convicted of securities fraud
A US federal court has found Andrew Left guilty on multiple counts of securities fraud, alleging he manipulated markets between 2018 and 2023 to generate approximately $21 million in profits.

Andrew Left, the founder of activist short-selling firm Citron Research, has been convicted by a US federal court on multiple counts of securities fraud. Prosecutors allege that between 2018 and 2023, Left utilised media appearances and publications to manipulate stock markets and generate artificial hype while holding positions to profit from short-term price movements, netting approximately $21 million. The conviction carries a potential sentence of up to 25 years in federal prison.
The court highlighted specific instances of alleged misconduct, including a 2018 post on X where Left claimed Citron had purchased Nvidia shares, predicting they would reach $165 before $120. Nvidia shares subsequently rose to $154 before falling to $144. Prosecutors noted that Left cashed in on $960,000 in options purchased just before the post, rather than holding the shares to the predicted target.
Left has indicated he will appeal the decision. On Citron Research’s X account, he argued that “not once” during his trial “did anyone say I lied” and stated he “disagree[s] with the jury and this does not stop here.” First Assistant United States Attorney Bill Essayli stated that Left used his TV appearances to disguise his intentions and manipulate the market.
The verdict has sparked debate regarding the sustainability of the activist short-selling model. Dr Frank Zhang of the Yale School of Management told The New York Times that the trial has made activist short sellers a “dying breed” and will scare them “into silence.” This sentiment is echoed by the recent closures of prominent firms; Jim Chanos shut down Chanos & Co. in 2023, and Hindenburg Research announced its disbandment in 2025, with founder Nathan Anderson citing the general pressure and stress of running a short-focused hedge fund.
However, not all experts believe the verdict will devastate the broader industry. Scott Nations, president of Nations Indexes, told Reuters he does not believe the Left trial will have any effect on “short selling in general,” arguing the case is more troubling for activist-style investors whose strategy relies on broadcasting displeasure. Peter Molk, a law professor at the University of Florida, noted that the costs to short sellers of making the wrong guess are huge, contributing to a chilling effect on the sector.


